Renaissance Technologies - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 61 filers reported holding CARDIFF ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2023$214
-53.3%
154,000
-50.5%
0.00%
-100.0%
Q2 2023$458
-16.3%
311,290
-6.0%
0.00%0.0%
Q1 2023$547
-20.4%
331,308
-32.5%
0.00%0.0%
Q4 2022$687
-99.9%
490,990
+16.4%
0.00%0.0%
Q3 2022$650,000
-59.4%
421,988
-42.0%
0.00%
-50.0%
Q2 2022$1,601,000
+31.3%
727,616
+48.1%
0.00%
+100.0%
Q1 2022$1,219,000
-9.5%
491,458
+82.8%
0.00%0.0%
Q2 2020$1,347,000268,8000.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
ELKHORN PARTNERS LIMITED PARTNERSHIP 45,000$630.04%
FinDec Wealth Services, Inc. 16,000$22,2400.02%
DENVER WEALTH MANAGEMENT, INC. 18,235$25,3470.02%
Atom Investors LP 18,298$25,4340.01%
Laurion Capital Management LP 722,100$1,003,7190.01%
MAI Capital Management 224,749$312,4010.01%
Callan Capital, LLC 31,147$43,2940.01%
GSA CAPITAL PARTNERS LLP 25,975$360.00%
Tortoise Investment Management, LLC 15,000$20,8500.00%
America First Investment Advisors, LLC 4,000$5,5600.00%
View complete list of CARDIFF ONCOLOGY INC shareholders